Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.3B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Advanced Micro Devices
AMD
|
+$925M |
| 4 |
S&P Global
SPGI
|
+$894M |
| 5 |
Tesla
TSLA
|
+$716M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$1.08B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$972M |
| 3 |
Merck
MRK
|
+$295M |
| 4 |
Exelon
EXC
|
+$259M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.39% |
| 2 | Financials | 13.32% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TTOO
3701
DELISTED
T2 Biosystems, Inc
TTOO
| $828K | ﹤0.01% |
316
+13
| +4% | +$27.6K |
|
3702
SCYNEXIS
SCYX
$50.9M
| $827K | ﹤0.01% |
26,461
+4,843
| +22% | +$185K |
|
3703
GH Research
GHRS
$1.98B
| $822K | ﹤0.01% |
44,983
+350
| +0.8% | +$6.18K |
|
|
GOCO
3704
DELISTED
GoHealth
GOCO
| $822K | ﹤0.01% |
46,488
-3,978
| -8% | -$124K |
|
|
PHX
3705
DELISTED
PHX Minerals
PHX
| $821K | ﹤0.01% |
268,441
| – | – |
|
|
SWKH
3706
DELISTED
SWK Holdings
SWKH
| $819K | ﹤0.01% |
61,234
-7
| -0% | -$104 |
|
3707
authID Inc
AUID
$13.4M
| $818K | ﹤0.01% |
26,098
| – | – |
|
3708
Genasys
GNSS
$79.7M
| $817K | ﹤0.01% |
297,369
+6,182
| +2% | +$21.1K |
|
3709
Eton Pharmaceutcials
ETON
$1.3B
| $815K | ﹤0.01% |
186,971
+11,118
| +6% | +$43.7K |
|
3710
IZEA Worldwide
IZEA
$62.2M
| $811K | ﹤0.01% |
122,202
| – | – |
|
|
THRN
3711
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $808K | ﹤0.01% |
127,081
+82,126
| +183% | +$442K |
|
3712
Comstock Holding Companies
CHCI
$162M
| $806K | ﹤0.01% |
137,897
+2,520
| +2% | +$12.3K |
|
|
FNCH
3713
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $806K | ﹤0.01% |
5,348
+309
| +6% | +$71.3K |
|
|
RYM
3714
RYTHM Inc
RYM
$55.3M
| $803K | ﹤0.01% |
58
+7
| +14% | +$137K |
|
|
TBIO
3715
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $801K | ﹤0.01% |
8,289
+1,503
| +22% | +$228K |
|
3716
Grupo Cibest SA
CIB
$21.5B
| $796K | ﹤0.01% |
18,670
-407
| -2% | -$14.7K |
|
3717
MPLX
MPLX
$60.8B
| $792K | ﹤0.01% |
23,887
+192
| +0.8% | +$6.2K |
|
|
IMBI
3718
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $792K | ﹤0.01% |
131,459
+3,543
| +3% | +$22K |
|
3719
Greene County Bancorp
GCBC
$590M
| $786K | ﹤0.01% |
35,192
+8,570
| +32% | +$174K |
|
3720
Pyxis Oncology
PYXS
$207M
| $786K | ﹤0.01% |
194,577
+13,105
| +7% | +$95.8K |
|
|
NEXI
3721
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $782K | ﹤0.01% |
7,433
-405
| -5% | -$29.7K |
|
|
VORB
3722
DELISTED
Virgin Orbit Holdings, Inc. Common Stock
VORB
| $781K | ﹤0.01% |
107,024
+85,773
| +404% | +$623K |
|
3723
Assembly Biosciences
ASMB
$524M
| $779K | ﹤0.01% |
31,522
-11,425
| -27% | -$245K |
|
|
PTN
3724
Palatin Technologies
PTN
$13.5M
| $778K | ﹤0.01% |
1,353
+19
| +1% | +$9.9K |
|
|
FLZH
3725
Flash Sports & Media Holdings
FLZH
$74.4M
| $774K | ﹤0.01% |
2,886
| – | – |
|
Similar funds
Geode Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q1 2022 filing shows 137 new, 3,082 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
- Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
- Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
- Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
- Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
- Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
- Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.
Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.